查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573251

慢性病管理市場：按疾病類型、產品類型、最終用戶、護理類型、交付模式 - 2025-2030 年全球預測

Chronic Disease Management Market by Disease Type (Cancer, Cardiovascular Diseases, Chronic Kidney Diseases), Product Type (Devices, Drugs, Services), End User, Care Type, Delivery Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年慢性病管理市場價值為93.3億美元，預計2024年將達到101.2億美元，複合年成長率為7.10%，到2030年將達到150.9億美元。

慢性病管理 (CDM) 包括旨在管理和改善患有糖尿病、心血管疾病和氣喘等長期非傳染性疾病的患者的健康狀況的全面、持續的護理和策略。由於人口老化、久坐的生活方式和不健康的飲食，慢性病在全球普遍流行，因此需要清潔發展機制。 CDM 的應用多種多樣，包括遠端醫療服務、病患教育、生活方式指導和藥物管理，以確保有效的治療依從性、減少住院治療並提高生活品質。主要的最終用途部門包括醫院、診所、以患者為中心的組織和居家醫療，這些部門擴大採用 CDM 解決方案來提高護理效率。

主要市場統計
基準年[2023] 93.3億美元
預測年份 [2024] 101.2億美元
預測年份 [2030] 150.9億美元
複合年成長率（%） 7.10%

影響該市場成長的關鍵因素包括健康監測設備的技術進步、遠距遠端醫療的日益普及以及將人工智慧 (AI) 整合到患者治療計劃中進行預測分析。提供遠端監控和資料分析的穿戴式技術和行動醫療應用程式中存在的最新機會將極大地提高患者的參與度和對處方治療方法的依從性。公司應該利用這些機會，推動以患者為中心的平台創新，整合人工智慧和物聯網，實現即時健康追蹤和個人化護理。

然而，挑戰依然存在，包括資料隱私問題、醫療保健 IT 系統之間的互通性有限以及缺乏熟悉新興醫療技術的熟練專業人員。經濟差異影響清潔發展機制解決方案的取得並阻礙市場滲透，特別是在低收入地區。公司必須專注於建立安全、可互通的系統，優先考慮患者資料的安全性，同時倡導擴大服務不足市場准入的政策。

為了促進成長和創新，公司可以探索人工智慧驅動的預測分析、用於安全資料共用的區塊鏈以及開發低成本、擴充性的數位健康平台等途徑。 CDM市場是一個充滿活力、以成長為導向的市場，以基於價值的護理模式為中心，旨在提高慢性病管理的整體效率和有效性。

市場動態：快速發展的慢性病管理市場的關鍵市場洞察

供需的動態交互作用正在改變慢性病管理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病流行增加了對有效管理解決方案的需求
    • 醫療保健技術的進步提高了監測和管理慢性病的能力
    • 提高醫療保健提供者和患者對慢性病管理重要性的認知
    • 透過專注於慢性病管理的創新醫療服務模式改善患者治療結果和體驗
  • 市場限制因素
    • 先進治療、技術和長期照護相關的高成本
    • 對資料外洩、未授權存取和敏感病患資訊遺失的擔憂
  • 市場機會
    • 擴展行動醫療平台以解決服務不足社區的慢性病管理問題
    • 將人工智慧融入慢性病管理，提供個人化治療方案
    • 開發遠端監控解決方案以減少慢性疾病患者的再入院率
  • 市場挑戰
    • 由於各個醫療保健提供者、專家和看護者之間缺乏協調，導致護理和溝通不一致
    • 難以確保患者遵守規定的治療計劃

波特五力：駕馭慢性病管理市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解慢性病管理市場的外部影響

外部宏觀環境因素對慢性病管理市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解慢性病管理市場的競爭格局

慢性病管理市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 慢性病管理市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估慢性病管理市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了慢性病管理市場的成功之路

慢性病管理市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、核准核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病的盛行率不斷增加，增加了對有效管理解決方案的需求。
      • 醫療保健技術的進步增強了監測和管理慢性病的能力
      • 提高醫療專業人員和患者對慢性病管理重要性的認知
      • 專注於改善病患治療結果和體驗的創新醫療服務模式
    • 抑制因素
      • 先進治療、技術和長期照護相關的高成本
      • 對資料外洩、未授權存取和敏感病患資訊遺失的擔憂
    • 機會
      • 擴展行動醫療平台以解決服務不足社區的慢性病管理問題
      • 將人工智慧融入慢性病管理，實現個人化治療計劃
      • 開發遠端監控解決方案以減少慢性疾病患者的再入院率
    • 任務
      • 不同醫療保健提供者、專家和看護者之間缺乏協調導致護理不一致和溝通差距
      • 難以確保患者遵守規定的治療計劃
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章慢性病管理市場：依疾病類型

  • 癌症
  • 心血管疾病
  • 慢性腎臟病
  • 慢性呼吸道疾病
  • 糖尿病

第7章慢性病管理市場：依產品類型

  • 裝置
    • 診斷設備
    • 監控裝置
    • 治療設備
  • 藥物
    • 止痛藥
    • 抗高血壓藥
    • 支氣管擴張劑
    • 胰島素
  • 服務
    • 家庭保健
    • 遠端醫療

第8章慢性病管理市場：依最終使用者分類

  • 診所
  • 家庭護理設置
  • 醫院
  • 長期照護中心

第9章按護理類型分類的慢性病管理市場

  • 專業護理
  • 自我治療

第10章以交付方式分類的慢性病管理市場

  • 雲端基礎
  • 本地

第11章美洲慢性病管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太慢性病管理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲慢性病管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C62918B2F

The Chronic Disease Management Market was valued at USD 9.33 billion in 2023, expected to reach USD 10.12 billion in 2024, and is projected to grow at a CAGR of 7.10%, to USD 15.09 billion by 2030.

Chronic Disease Management (CDM) involves comprehensive, continuous care and strategies designed to manage and improve patients' well-being suffering from long-lasting, non-communicable ailments such as diabetes, cardiovascular disease, and asthma. The necessity of CDM arises from the growing global prevalence of chronic diseases fueled by aging populations, sedentary lifestyles, and unhealthy diets. Its applications span telehealth services, patient education, lifestyle coaching, and medication management to ensure effective treatment adherence, reduce hospitalizations, and improve life quality. End-use sectors primarily include hospitals, clinics, patient-centric organizations, and home healthcare, increasingly adopting CDM solutions to enhance care efficiency.

KEY MARKET STATISTICS
Base Year [2023] USD 9.33 billion
Estimated Year [2024] USD 10.12 billion
Forecast Year [2030] USD 15.09 billion
CAGR (%) 7.10%

Key factors influencing this market's growth include technological advancements in health monitoring devices, the rising adoption of telemedicine, and the integration of Artificial Intelligence (AI) for predictive analytics in patient treatment plans. Latest opportunities present in wearable technology and mobile health apps, which offer remote monitoring and data analytics, significantly improve patient engagement and adherence to prescribed therapies. Businesses should leverage these opportunities by fostering innovations in patient-centric platforms that integrate AI and IoT for real-time health tracking and personalized care.

However, challenges persist in data privacy concerns, limited interoperability between healthcare IT systems, and a lack of skilled professionals adept in emerging health technologies. Economic disparities impact access to CDM solutions, particularly in low-income regions, hindering market penetration. Companies must focus on building secure, interoperable systems that prioritize patient data security while advocating for policies that expand access to underserved markets.

To spur growth and innovation, businesses can explore avenues in AI-driven predictive analytics, blockchain for secure data sharing, and the development of low-cost, scalable digital health platforms. The CDM market represents a dynamic, growth-oriented landscape pivoting towards value-based care models, aiming to enhance the overall efficiency and efficacy of chronic disease management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Disease Management Market

The Chronic Disease Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
    • Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
    • Growing awareness among healthcare providers and patients about the importance of chronic disease management
    • Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
  • Market Restraints
    • High cost associated with advanced treatments, technologies, and long-term care
    • Concerns over data breaches, unauthorized access, and loss of sensitive patient information
  • Market Opportunities
    • Expansion of mobile health platforms addressing chronic disease management in underserved communities
    • Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
    • Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
  • Market Challenges
    • Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
    • Difficulties in ensuring patients adherence to their prescribed treatment plans

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Disease Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Disease Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Disease Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Disease Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Disease Management Market

A detailed market share analysis in the Chronic Disease Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Disease Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Disease Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Disease Management Market

A strategic analysis of the Chronic Disease Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Disease Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, Glooko, Inc., Health Catalyst Inc., Hinge Health, Inc., Lark Technologies, Inc., Livongo Health, Inc., Medtronic plc, Merck & Co., Inc., MySugr GmbH, Novo Nordisk A/S, Omada Health, Inc., Propeller Health, Roche Holding AG, Sanofi S.A., Virta Health Corp., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Disease Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Cancer, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Respiratory Diseases, and Diabetes.
  • Based on Product Type, market is studied across Devices, Drugs, and Services. The Devices is further studied across Diagnostic Devices, Monitoring Devices, and Therapeutic Devices. The Drugs is further studied across Analgesics, Antihypertensive, Bronchodilators, and Insulin. The Services is further studied across Home Healthcare and Telemedicine.
  • Based on End User, market is studied across Clinics, Homecare Settings, Hospitals, and Long-term Care Centers.
  • Based on Care Type, market is studied across Professional Care and Self-care.
  • Based on Delivery Mode, market is studied across Cloud-based and On-premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
      • 5.1.1.2. Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
      • 5.1.1.3. Growing awareness among healthcare providers and patients about the importance of chronic disease management
      • 5.1.1.4. Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced treatments, technologies, and long-term care
      • 5.1.2.2. Concerns over data breaches, unauthorized access, and loss of sensitive patient information
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of mobile health platforms addressing chronic disease management in underserved communities
      • 5.1.3.2. Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
      • 5.1.3.3. Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
      • 5.1.4.2. Difficulties in ensuring patients adherence to their prescribed treatment plans
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chronic Disease Management Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Cardiovascular Diseases
  • 6.4. Chronic Kidney Diseases
  • 6.5. Chronic Respiratory Diseases
  • 6.6. Diabetes

7. Chronic Disease Management Market, by Product Type

  • 7.1. Introduction
  • 7.2. Devices
    • 7.2.1. Diagnostic Devices
    • 7.2.2. Monitoring Devices
    • 7.2.3. Therapeutic Devices
  • 7.3. Drugs
    • 7.3.1. Analgesics
    • 7.3.2. Antihypertensive
    • 7.3.3. Bronchodilators
    • 7.3.4. Insulin
  • 7.4. Services
    • 7.4.1. Home Healthcare
    • 7.4.2. Telemedicine

8. Chronic Disease Management Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Homecare Settings
  • 8.4. Hospitals
  • 8.5. Long-term Care Centers

9. Chronic Disease Management Market, by Care Type

  • 9.1. Introduction
  • 9.2. Professional Care
  • 9.3. Self-care

10. Chronic Disease Management Market, by Delivery Mode

  • 10.1. Introduction
  • 10.2. Cloud-based
  • 10.3. On-premise

11. Americas Chronic Disease Management Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Chronic Disease Management Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Chronic Disease Management Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AstraZeneca plc
  • 3. Boehringer Ingelheim GmbH
  • 4. DexCom, Inc.
  • 5. Eli Lilly and Company
  • 6. Glooko, Inc.
  • 7. Health Catalyst Inc.
  • 8. Hinge Health, Inc.
  • 9. Lark Technologies, Inc.
  • 10. Livongo Health, Inc.
  • 11. Medtronic plc
  • 12. Merck & Co., Inc.
  • 13. MySugr GmbH
  • 14. Novo Nordisk A/S
  • 15. Omada Health, Inc.
  • 16. Propeller Health
  • 17. Roche Holding AG
  • 18. Sanofi S.A.
  • 19. Virta Health Corp.
  • 20. Welldoc, Inc.

LIST OF FIGURES

  • FIGURE 1. CHRONIC DISEASE MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CHRONIC DISEASE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHRONIC DISEASE MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)

TABLE 333.